Nicolas Gendron: A Very Nice Demonstration by The Authors – Coffee is Associated with Reduced Risk of VTE
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, reposted from RPTH Journal on LinkedIn:
”For the Caféinomaniaces team: good news!
Coffee consumption is associated with a reduced risk of thromboembolic venous disease, including pulmonary embolism.
A very nice demonstration by the authors, carried out on a large cohort.
Read more in RPTH Journal.”
RPTH Journal shared on LinkedIn:
”Coffee lovers, rejoice
This new study from Melliane Muteba Olsen and team demonstrated that drinking 1–2 cups a day is linked to a 21% lower risk of VTE, especially PE.
In a massive cohort study (112K+ people), moderate coffee intake showed protective effects.”
Read the full article in RPTH.
Article: Repeated measures of coffee consumption and risk of future incident venous thromboembolism—the Trøndelag Health Study and the Tromsø study
Authors: Melliane Muteba Olsen, Sigrid K. Brækkan, Kristian Hveem, Kjersti Grønning, John-Bjarne Hansen

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline